Researchers at Beijing Institute of Microbiology & Epidemiology Have Reported New Data on Vaccines (Inhalable Vaccine of Bacterial Culture Supernatant Extract Mediates Protection Against Fatal Pulmonary Anthrax).

Researchers at the Beijing Institute of Microbiology & Epidemiology have developed an inhalable vaccine for protection against fatal pulmonary anthrax. The vaccine, derived from a Bacillus anthracis strain with low protease activity, induced strong immune responses and provided full protection in mice against lethal aerosol challenges. This next-generation vaccine shows promise for inhalational immunization against pulmonary anthrax, offering superior immunoprotection compared to existing injectable vaccines. [Extracted from the article]